PrEPping for a healthier future – a concise update of current pharmacological HIV-prophylaxis practices-Reference-Cited by-同舟云学术

PrEPping for a healthier future – a concise update of current pharmacological HIV-prophylaxis practices

Published:2020-07-07 Issue: Volume: Page:77-78
ISSN:2706-9613
Container-title:South African General Practitioner
language:en
Short-container-title:SAGP

Author:

Steyn SF¹,Wolmarans DW¹,Brand L¹

Affiliation:

1. North-West University

Abstract

Pre-exposure prophylaxis (PrEP) refers to the use of antiretroviral drugs to prevent one from acquiring human immunodeficiency virus (HIV) infection when engaging in high-risk sexual behaviour. Adequate PrEP initiation is key in the clinical outcome and survival of not only vulnerable and high-risk populations, but also to ensure that a society which is free of HIV, is built.

Publisher

Medpharm Publications

Reference28 articles.

1. United Nations Programme on AIDS. Global HIV & AIDS statistics - 2019 fact sheet. 2019. [cited 2020 08 Apr]. Available from: https://www.unaids.org/en/resources/fact-sheet.

2. World Health Organization. WHO fact sheet: HIV/AIDS. 2020. [cited 2020 08 Apr]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.

3. Huang X, Hou K, Song A, et al. Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: a systematic review and meta-analysis. Frontiers in Pharmacology. 2018;9:799. https://doi.org/10.3389/fphar.2018.00799.

4. Fonner V, Dalglish S, Kennedy C, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973-83. https://doi.org/10.1097/QAD.0000000000001145.

5. World Health Organization. WHO PrEP guidance. 2019. [cited 2020 08 Apr]. Available from: https://www.gfmer.ch/SRH-Course-2019/adolescent-health/pdf/WHO-PrEP-guidance-2019.pdf.